These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 26520047)
21. HPV vaccination. Stanley M; O'Mahony C; Barton S BMJ; 2014 Jul; 349():g4783. PubMed ID: 25073784 [No Abstract] [Full Text] [Related]
22. A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Graham DM; Isaranuwatchai W; Habbous S; de Oliveira C; Liu G; Siu LL; Hoch JS Cancer; 2015 Jun; 121(11):1785-92. PubMed ID: 25867018 [TBL] [Abstract][Full Text] [Related]
23. Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers. Arya SC; Agarwal N Hum Vaccin Immunother; 2012 Jul; 8(7):959. PubMed ID: 22777098 [No Abstract] [Full Text] [Related]
24. [Papillomavirus, could we speak about cancer and prevention?]. Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106 [No Abstract] [Full Text] [Related]
25. The human papilloma virus, the vaccines, and oral and oropharyngeal squamous cell carcinoma: what every dentist should know. Closmann JJ Gen Dent; 2007; 55(3):252-4; quiz 255, 264. PubMed ID: 17511372 [TBL] [Abstract][Full Text] [Related]
26. [Human papillomavirus (HPV) vaccination in males : evidence and practice]. Perrin A; Iselin C Rev Med Suisse; 2019 Nov; 15(673):2202-2204. PubMed ID: 31778050 [TBL] [Abstract][Full Text] [Related]
27. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Brisson M; Laprise JF; Drolet M; Van de Velde N; Franco EL; Kliewer EV; Ogilvie G; Deeks SL; Boily MC Vaccine; 2013 Aug; 31(37):3863-71. PubMed ID: 23830974 [TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Berman TA; Schiller JT Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680 [TBL] [Abstract][Full Text] [Related]
29. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline]. Gross G; Gissmann L; Hillemanns P; Ikenberg H; Kaufmann AM; Petry KU; Pfister H; Schneede P; Schneider A; Smola S; Dtsch Med Wochenschr; 2010 May; 135(21):1083-6. PubMed ID: 20486060 [No Abstract] [Full Text] [Related]
30. Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus. Dadar M; Chakraborty S; Dhama K; Prasad M; Khandia R; Hassan S; Munjal A; Tiwari R; Karthik K; Kumar D; Iqbal HMN; Chaicumpa W Front Immunol; 2018; 9():2478. PubMed ID: 30483247 [TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus vaccines and anal carcinoma. Franceschi S; De Vuyst H Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940 [TBL] [Abstract][Full Text] [Related]
32. Public awareness of human papillomavirus as a causative factor for oropharyngeal cancer. Williams MU; Carr MM; Goldenberg D Otolaryngol Head Neck Surg; 2015 Jun; 152(6):1029-34. PubMed ID: 25820579 [TBL] [Abstract][Full Text] [Related]
33. Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire. Anderson S; Isaac A; Jeffery CC; Robinson JL; Isaac DM; Korownyk C; Biron VL; Seikaly H J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):61. PubMed ID: 29073940 [TBL] [Abstract][Full Text] [Related]
34. Utility of the Human Papillomavirus Vaccination in Management of HPV-associated Cutaneous Lesions. Gay J; Johnson N; Kavuru V; Phillips M Skin Therapy Lett; 2021 Mar; 26(2):6-8. PubMed ID: 33769773 [TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus (HPV): making the case for 'Immunisation for All'. Prue G; Lawler M; Baker P; Warnakulasuriya S Oral Dis; 2017 Sep; 23(6):726-730. PubMed ID: 27492979 [TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus-related malignancies in HIV infection: anal and oropharyngeal cancers. Wilkin TJ Top Antivir Med; 2018 Sep; 26(3):85-88. PubMed ID: 30384331 [TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy? Osazuwa-Peters N Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883 [TBL] [Abstract][Full Text] [Related]
38. [Prevention of HPV-induced diseases by prophylactic vaccination]. Wieland U; Kreuter A Hautarzt; 2021 Feb; 72(2):106-113. PubMed ID: 33337514 [TBL] [Abstract][Full Text] [Related]
39. US Health Care Clinicians' Knowledge, Attitudes, and Practices Regarding Human Papillomavirus Vaccination: A Qualitative Systematic Review. Rosen BL; Shepard A; Kahn JA Acad Pediatr; 2018 Mar; 18(2S):S53-S65. PubMed ID: 29502639 [TBL] [Abstract][Full Text] [Related]
40. Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action. Sharma SJ; Schartinger VH; Wuerdemann N; Langer C; Möllenhoff K; Collin L; Sutton L; Riedl D; Kreuter A; Lechner M; Wieland U; Klussmann JP Oncol Res Treat; 2022; 45(10):561-567. PubMed ID: 35850111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]